Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 HCPCS code J2730

Injection, pralidoxime chloride, up to 1 gm

This code represents the drug only and does not include the administration. Separate codes may be required for the administration of the injection depending on the route (IM, IV, SC). Check payer guidelines for specific billing instructions.

Modifiers may be applicable to J2730 to provide additional information about the circumstances of the drug's provision. Consult modifier guidelines for appropriate use.

Medical necessity for J2730 is established by the diagnosis of a condition requiring treatment with pralidoxime chloride, typically organophosphate poisoning. Documentation should clearly link the administration of the drug to the diagnosis and the patient's presenting symptoms.

In simple words: This code covers the cost of the drug pralidoxime chloride, which is given as a shot to treat poisoning from certain chemicals or drugs. It helps reverse the effects of the poison, like muscle weakness and paralysis. The code is for the medication itself, not for giving the shot.

This code represents the supply of up to 1 gram of pralidoxime chloride for injection. Pralidoxime chloride is used to treat organophosphate poisoning, which can cause life-threatening symptoms like muscle weakness or paralysis. It is administered via intramuscular (IM), intravenous (IV) or subcutaneous (SC) routes.

Example 1: A patient presents to the emergency room with organophosphate poisoning after accidentally inhaling pesticides. Pralidoxime chloride is administered intravenously to counteract the effects of the poison., A farmer is brought to the hospital exhibiting symptoms of nerve agent exposure. J2730 is used to bill for the pralidoxime chloride administered intramuscularly as part of their treatment., A child is admitted after ingesting a large amount of insecticide. Pralidoxime chloride is given subcutaneously to help reverse the toxic effects.

Documentation should support the medical necessity for the administration of pralidoxime chloride, including the diagnosis of organophosphate or other qualifying poisoning, the dosage administered, and the route of administration.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.